FromAmountPurposeYear
$250K
To support pancreatic cancer research program
2024
$50K
OPERATIONAL SUPPORT
2024
$5K
UNRESTRICTED GENERAL SUPPORT
2024
$150
GENERAL EXEMPT PURPOSE
2024
$3.0M
ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF A NORMAL SIGNAL THAT IS MISSING IN MPN/SAML PATIENTS.
2023
$2.7M
ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECOND DIAGNOSTIC RESEARCH PROJECT IS TO DEVELOP AND DEPLOY AN ULTRA-RAPID WHOLE GENOMIC SEQUENCING TEST TO IDENTIFY DRUG TREATMENT OPTIONS FOR PATIENTS WHO HAVE TRANSITIONED FROM MPN TO SAML.
2023
$85K
KIDNEY DISEASE TREATMENT AND RESEARCH
2023
$44K
GRANT AWARD-MIND/CROWD PROJECT
2023
$15K
For grant recipient's exempt purposes
2023
$10K
GENERAL PROGRAM ASSI
2023
$5K
UNRESTRICTED GENERAL SUPPORT
2023
$3.1M
ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECOND DIAGNOSTIC RESEARCH PROJECT IS TO DEVELOP AND DEPLOY AN ULTRA-RAPID WHOLE GENOMIC SEQUENCING TEST TO IDENTIFY DRUG TREATMENT OPTIONS FOR PATIENTS WHO HAVE TRANSITIONED FROM MPN TO SAML.
2022
$1.3M
ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF A NORMAL SIGNAL THAT IS MISSING IN MPN/SAML PATIENTS.
2022
$120K
KIDNEY DISEASE TREATMENT AND RESEARCH
2022
$50K
OPERATIONAL SUPPORT
2022
$40K
For grant recipient's exempt purposes
2022
$9K
DONATIONS MADE TO TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION
2022
$547K
PARKINSON'S RESEARCH
2021
$60K
KIDNEY DISEASE TREATMENT AND RESEARCH
2021
$50K
OPERATIONAL SUPPORT
2021
$13K
For grant recipient's exempt purposes
2021
$13K
For grant recipient's exempt purposes
2021
$78K
TO ESTABLISH THE OCNDS RESEARCH PROGRAM
2020
$50K
DESIGNATED SUPPORT FOR COVID-19 TESTING
2020
$50K
SUPPORT CHARITY ORG
2020
$33K
FOR RECIPIENT'S EXEMPT PURPOSE
2020
$25K
KIDNEY DISEASE TREATMENT AND RESEARCH
2020
$25K
OPERATIONAL SUPPORT
2020
$15K
For grant recipient's exempt purposes
2020
$60K
KIDNEY DISEASE TREATMENT AND RESEARCH
2019
$19K
For grant recipient's exempt purposes
2019
$50K
OPERATIONAL SUPPORT
2018
$3K
Gainey Village Hike
2018
$2K
Fitness for the Cure (formerly known as Cycle for the Cure)
2018
$6K
HEALTH & HUMAN SERVICES
2017
$5K
GENERAL OPERATING EXPENDITURES
2017